van de Ven, R., Reurs, A. W., Wijnands, P. G. J. T. B., van Wetering, S., Kruisbeek, A. M., Hooijberg, E., . . . de Gruijl, T. D. (2012). Exposure of CD34+ precursors to cytostatic anthraquinone-derivatives induces rapid dendritic cell differentiation: Implications for cancer immunotherapy. Cancer Immunology, Immunotherapy, 61(2), 181-191. https://doi.org/10.1007/s00262-011-1039-x
Chicago Style (17th ed.) Citationvan de Ven, Rieneke, Anneke W. Reurs, Pepijn G. J. T. B. Wijnands, Sandra van Wetering, Ada M. Kruisbeek, Erik Hooijberg, George L. Scheffer, Rik J. Scheper, and Tanja D. de Gruijl. "Exposure of CD34+ Precursors to Cytostatic Anthraquinone-derivatives Induces Rapid Dendritic Cell Differentiation: Implications for Cancer Immunotherapy." Cancer Immunology, Immunotherapy 61, no. 2 (2012): 181-191. https://doi.org/10.1007/s00262-011-1039-x.
MLA (9th ed.) Citationvan de Ven, Rieneke, et al. "Exposure of CD34+ Precursors to Cytostatic Anthraquinone-derivatives Induces Rapid Dendritic Cell Differentiation: Implications for Cancer Immunotherapy." Cancer Immunology, Immunotherapy, vol. 61, no. 2, 2012, pp. 181-191, https://doi.org/10.1007/s00262-011-1039-x.